Summit Therapeutics Inc.

SMMT

$15.61

Name : Summit Therapeutics Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $12,452,871,168.00

EPSttm : -1.11

Summit Therapeutics Inc.

$15.61

4.70%

$0.77

SMMT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

26.97

Margin Of Safety %

Put/Call OI Ratio

0.65

EPS Next Q Diff

0.03

EPS Last/This Y

0.58

EPS This/Next Y

-0.03

Price

15.61

Target Price

29.06

Analyst Recom

1.67

Performance Q

11.42

Upside

-193.3%

Beta

-1.51

Ticker: SMMT

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	SMMT	13.77	0.57	0.51	154230
2026-08-31	SMMT	13.62	0.55	1.32	147657
2026-09-01	SMMT	14.16	0.56739870669457	0.2326579261025	150522
2026-09-02	SMMT	14.54	0.56	0.40	151945
2026-09-03	SMMT	17.12	0.55	0.63	153894
2026-09-04	SMMT	17.6	0.59	0.23	163760
2026-09-08	SMMT	17.28	0.59	0.29	160073
2026-09-09	SMMT	17.53	0.58	1.31	162828
2026-09-10	SMMT	17.01	0.60	1.16	167566
2026-09-11	SMMT	17.57	0.62	0.28	170483
2026-09-14	SMMT	18.42	0.63	0.59	168812
2026-09-15	SMMT	17.4	0.63	0.25	172178
2026-09-16	SMMT	17.32	0.62	0.35	180032
2026-09-17	SMMT	17.71	0.61	0.72	183356
2026-09-18	SMMT	17.85	0.65	0.29	191047
2026-09-21	SMMT	16.65	0.62	0.42	169965
2026-09-22	SMMT	17.11	0.62	0.92	176328
2026-09-23	SMMT	16.44	0.66	0.76	182847
2026-09-24	SMMT	16.39	0.66	0.47	185884
2026-09-25	SMMT	15.61	0.65	1.95	203034
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	SMMT	13.71	6.9	-	-0.86
2026-08-31	SMMT	13.62	7.2	-	-0.86
2026-09-01	SMMT	14.17	7.2	-	-0.86
2026-09-02	SMMT	14.61	7.2	-	-0.86
2026-09-03	SMMT	17.11	7.2	-	-0.86
2026-09-04	SMMT	17.60	7.2	-	-0.86
2026-09-08	SMMT	17.27	7.3	-	-0.86
2026-09-09	SMMT	17.52	7.3	-	-0.86
2026-09-10	SMMT	17.00	7.3	-	-0.86
2026-09-11	SMMT	17.56	7.3	-	-0.86
2026-09-14	SMMT	18.42	7.3	-	-0.86
2026-09-15	SMMT	17.41	7.2	-	-0.86
2026-09-16	SMMT	17.41	7.2	-	-0.86
2026-09-17	SMMT	17.70	7.3	-	-0.86
2026-09-18	SMMT	17.85	7.2	-	-0.86
2026-09-21	SMMT	16.90	7.2	-	-0.86
2026-09-22	SMMT	17.11	7.2	-	-0.86
2026-09-23	SMMT	16.44	7.2	-	-0.86
2026-09-24	SMMT	16.39	7.2	-	-0.86
2026-09-25	SMMT	15.61	7.1	-	-0.86
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	SMMT	1.23	12.00	24.57
2026-08-31	SMMT	1.23	11.98	24.57
2026-09-01	SMMT	1.23	11.98	24.57
2026-09-02	SMMT	1.23	11.98	24.57
2026-09-03	SMMT	1.23	11.98	24.57
2026-09-04	SMMT	1.23	11.98	24.57
2026-09-08	SMMT	1.23	11.90	24.57
2026-09-09	SMMT	1.23	11.90	24.57
2026-09-10	SMMT	1.23	11.90	24.57
2026-09-11	SMMT	1.23	11.90	27.13
2026-09-14	SMMT	1.23	11.90	27.13
2026-09-15	SMMT	1.23	11.90	27.13
2026-09-16	SMMT	1.23	11.90	27.13
2026-09-17	SMMT	1.23	11.90	27.13
2026-09-18	SMMT	1.23	11.90	27.13
2026-09-21	SMMT	1.23	12.34	27.13
2026-09-23	SMMT	1.23	12.34	27.13
2026-09-24	SMMT	1.23	12.34	27.13
2026-09-25	SMMT	1.23	12.34	26.97
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.28

Avg. EPS Est. Current Quarter

-0.21

Avg. EPS Est. Next Quarter

-0.25

Insider Transactions

1.23

Institutional Transactions

12.34

Beta

-1.51

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

57.7

Max Drawdown 5-Year %

-87.9

Target Price

29.06

P/E

Forward P/E

PEG

P/S

P/B

19.65

P/Free Cash Flow

EPS

-1.12

Average EPS Est. Cur. Y

-0.86

EPS Next Y. (Est.)

-0.89

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.74

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ SMMT Healthcare

$15.61

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

8/20

Pullback

9/25

Volume

9/15

Valuation

12/20

TP/AR

1/10

Options

3/10

RSI

46.6

Range 1M

42.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

2/25

Growth

12/30

Estimates

0/20

Inst/Vol

7/15

Options

2/10

EPS Yr

17.5%

EPS NY

2.4%

52W%

21.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +86.2% upside

Quality

2/30

Valuation

14/30

Growth

7/25

Stability

7/10

LT Trend

4/5

Upside

+86.2%

Quality

SMMT — P/E HistoricalBiotechnology

Summit Therapeutics Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 265

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of non-small lung cancer (NSCLC) and colorectal cancer (CRC). The company has also combined ivonescimab with chemotherapy, which is in phase III clinical trial for the patients with epidermal growth factor receptor, mutated, and locally advanced or metastatic non-squamous NSCLC; first-line metastatic NSCLC; and first-line unresectable metastatic CRC. It markets its products in the United states, Canada, Europe, Japan, Latin America, Middle East, and Africa. The company was founded in 2003 and is headquartered in Miami, Florida.

SMMT

Latest News

—

Caricamento notizie per SMMT…

stock quote shares SMMT – Summit Therapeutics Inc Stock Price stock today

news today SMMT – Summit Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch SMMT – Summit Therapeutics Inc yahoo finance google finance

stock history SMMT – Summit Therapeutics Inc invest stock market

stock prices SMMT premarket after hours

ticker SMMT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SMMT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y